Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

Memorial Sloan Kettering Cancer Center (MSK)

Status: Active, not recruiting

Conditions: Renal Cancer

Treatments: Behavioral: EuroQol EQ-5D 7-item questionnaire; Behavioral: (EORTC QLQ-C30) questionnaire

Study type: Observational

Funder types: Other

Identifiers

NCT01888198

MSKCC 13-116

Details and patient eligibility

About

The purpose of this study is to better understand how effective ablation is for destroying tumor cells in the kidney and whether quality of life is improved for patients. Participation in ARMOR may involve retrospective data collection only, combined retrospective and prospective data collection, or prospective data collection

Enrollment: 294 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Retrospective enrollment:

• Patients having undergone percutaneous, open or laparoscopic energy ablation of a renal mass.

Prospective enrollment:

• Patients scheduled to undergo, rather than having undergone, percutaneous, open or laparoscopic energy ablation of a renal mass.

Exclusion criteria

• Patients not having undergone, or considered candidates for percutaneous, open or laparoscopic energy ablation of a renal mass
• Non-English speaking patients
• Patients under the age of 18.

Trial design

294 participants in 1 patient group

renal mass ablation candidates

Description:

Standard of care interventions for the treatment of renal masses using energy ablation will be studied. Data collection can be divided into five basic categories: 1) Patient demographics and relevant history, 2) Renal mass characteristics, 3) Ablation procedure details, 4) Imaging studies, and 5) Patient-reported quality of life.

Treatment:

Behavioral: (EORTC QLQ-C30) questionnaire

Behavioral: EuroQol EQ-5D 7-item questionnaire